Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lormeau

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|January 1, 1994
Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin IIID Baruch, N Ajzenberg, C Denis, et al.
Thrombosis and Haemostasis|January 1, 1996
Heparin reverses the procoagulant properties of stimulated endothelial cellsY Cadroy, D Gaspin, D Dupouy, et al.
Biochimica Et Biophysica Acta|August 11, 1988
Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor IIP Sié, M Petitou, J C Lormeau, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparinsW Jeske, J C Lormeau, D Callas, et al.
Biochemical and Biophysical Research Communications|October 31, 1983
Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityJ Choay, M Petitou, J C Lormeau, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Long-term persistence of low-molecular-weight material with anti-factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbitV Peyrou, J C Lormeau, J P Hérault, et al.
Journal of Pharmaceutical Sciences|June 1, 1995
Molecular profiling and weight determination of heparins and depolymerized heparinsA Ahsan, W Jeske, D Hoppensteadt, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinaseJ P Hérault, A Bernat, A M Pflieger, et al.
Thrombosis Research|July 15, 1986
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis modelJ M Walenga, J Fareed, M Petitou, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|January 1, 1994
Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin IIID Baruch, N Ajzenberg, C Denis, et al.
Thrombosis and Haemostasis|January 1, 1996
Heparin reverses the procoagulant properties of stimulated endothelial cellsY Cadroy, D Gaspin, D Dupouy, et al.
Biochimica Et Biophysica Acta|August 11, 1988
Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor IIP Sié, M Petitou, J C Lormeau, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparinsW Jeske, J C Lormeau, D Callas, et al.
Biochemical and Biophysical Research Communications|October 31, 1983
Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityJ Choay, M Petitou, J C Lormeau, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Long-term persistence of low-molecular-weight material with anti-factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbitV Peyrou, J C Lormeau, J P Hérault, et al.
Journal of Pharmaceutical Sciences|June 1, 1995
Molecular profiling and weight determination of heparins and depolymerized heparinsA Ahsan, W Jeske, D Hoppensteadt, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinaseJ P Hérault, A Bernat, A M Pflieger, et al.
Thrombosis Research|July 15, 1986
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis modelJ M Walenga, J Fareed, M Petitou, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Pageof 7